search
Back to results

Lung Cancer Early Diagnosis With Digital Tomosynthesis: Re-evaluation of Lung Nodule Detection Rate at 5 Years (SOS2)

Primary Purpose

Lung Cancer

Status
Completed
Phase
Phase 3
Locations
Italy
Study Type
Interventional
Intervention
diagnosis with tomosynthesis
Sponsored by
Ospedale Santa Croce-Carle Cuneo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Lung Cancer focused on measuring lung, cancer, early diagnosis, DTS

Eligibility Criteria

45 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • current or former smoker status;
  • for former smokers, the maximum time since quitting smoking must be below 10 years;
  • smoking history of at least 20 pack-years;
  • age 45-80 years;
  • no previous history of cancer in the 10 years before the beginning of the study;
  • be able to stand and hold the breath for 11 seconds during image acquisition;
  • previous participation to SOS trial.

Exclusion Criteria:

  • pregnancy

Sites / Locations

  • OSCroceCarle

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

diagnosis with tomosynthesis (DTS)

Arm Description

Single arm. Population: Subjects enrolled in previously closed SOS trial (high risk subjects for lung cancer) without confirmed lung cancer.

Outcomes

Primary Outcome Measures

To evaluate the lung cancer detection rate in the population of high risks subjects previously enrolled in lung cancer screening trial with chest digital tomosynthesis (SOS trial).
Lung cancer detection rate (primary endpoint)

Secondary Outcome Measures

Percentage of lung cancer addressed to radical surgery treatment
Sensitivity of DTS evaluating the number of lung cancer occurred in the population of SOS study in the last 5 years
Mortality
OS
Overall survival
QoL: quality of life: Percentage of partecipants changing their smoking habits
Percentage of partecipants changing their smoking habits after trial

Full Information

First Posted
July 20, 2018
Last Updated
September 13, 2018
Sponsor
Ospedale Santa Croce-Carle Cuneo
Collaborators
Fondazione CRC - Cuneo, University of Turin, Italy
search

1. Study Identification

Unique Protocol Identification Number
NCT03645018
Brief Title
Lung Cancer Early Diagnosis With Digital Tomosynthesis: Re-evaluation of Lung Nodule Detection Rate at 5 Years
Acronym
SOS2
Official Title
A Monocenter Prospective No-profit Interventional Study for Lung Cancer Early Diagnosis With Tomosynthesis: Re-evaluation of Lung Nodule Detection Rate at 5 Years
Study Type
Interventional

2. Study Status

Record Verification Date
September 2018
Overall Recruitment Status
Completed
Study Start Date
September 1, 2017 (Actual)
Primary Completion Date
August 31, 2018 (Actual)
Study Completion Date
August 31, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ospedale Santa Croce-Carle Cuneo
Collaborators
Fondazione CRC - Cuneo, University of Turin, Italy

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Lung cancer is the leading cause of cancer-related death around the world, it represents 13% of all new cancer diagnoses. The lung cancer incidence is gradually increasing, especially among women and young people, but the fraction of cured patient remains low. In 80% of cases lung cancer, in early phase, is treatable only with surgery without chemotherapy or adjuvant radiotherapy and the survival perspective at five years exceeds 70%. Several scientific guidelines recommends chest CT (computed tomography) in lung cancer screening. Digital tomosynthesis (DTS) is a limited angle tomography that allows reconstruction of coronal images from a set of projection acquired over a small angle of X-ray tube movement. Several studies demonstrates that DTS is a reasonable alternative to the CT and allows a better evaluation of suspects nodules compared to conventional chest RX.
Detailed Description
Lung cancer is the leading cause of cancer-related death around the world. In 2008 there were nearly 1.6 million new cases worldwide, accounting for the 12.7% of all new cancer diagnoses. Despite decreasing trends in smoking and resulting decrease in lung cancer mortality, the population at risk for lung cancer continues to be large. In the past years several programs have been developed to screen for lung cancer using low-dose chest computed radiography (CT). However, only recently different studies demonstrated a clear reduction in mortality. In particular, NLST low dose CT screening trial demonstrated a 6.7% reduction in the death rate compared to chest X-ray with a positive screening test rate for lung cancer detection of 24.2%, compared to 6.9% for conventional X-ray. Digital tomosynthesis (DTS) is a limited angle tomography that allows reconstruction of multiple image planes from a set of projection data acquired over a relatively small angle of X-ray tube movement. Although it does not have the spatial depth resolution of computed tomography, it provides high-resolution images in the sagittal planes at a lower dose and cost than CT. Several studies have shown that DTS offers advantages over conventional chest X-ray and comparable of those of CT. The Studio OSservazionale (SOS) was a clinical trial conducted within Santa Croce e Carle Hospital analysing smokers and former smokers aged 45-80 with no cancer diagnosis. All the subjects in whom a suspicious nodule was detected by DTS underwent diagnostic CT. The SOS study demonstrated that baseline DTS detected pulmonary abnormalities in 14.5% and lung cancer in 1.0% of the subjects, comparable to results that are obtained in CT screening programs. A second DTS, within the same study, executed one year later reported pulmonary abnormalities in 0.7% and lung cancer in 0.3% of the subjects.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lung Cancer
Keywords
lung, cancer, early diagnosis, DTS

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Model Description
Monocenter prospective no-profit single group interventional study.
Masking
None (Open Label)
Allocation
N/A
Enrollment
1341 (Actual)

8. Arms, Groups, and Interventions

Arm Title
diagnosis with tomosynthesis (DTS)
Arm Type
Experimental
Arm Description
Single arm. Population: Subjects enrolled in previously closed SOS trial (high risk subjects for lung cancer) without confirmed lung cancer.
Intervention Type
Diagnostic Test
Intervention Name(s)
diagnosis with tomosynthesis
Intervention Description
Re-evaluation of lung nodule detection rate at 5 years in patients with early diagnosis of lung cancer
Primary Outcome Measure Information:
Title
To evaluate the lung cancer detection rate in the population of high risks subjects previously enrolled in lung cancer screening trial with chest digital tomosynthesis (SOS trial).
Description
Lung cancer detection rate (primary endpoint)
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Percentage of lung cancer addressed to radical surgery treatment
Time Frame
1 year
Title
Sensitivity of DTS evaluating the number of lung cancer occurred in the population of SOS study in the last 5 years
Time Frame
1 year
Title
Mortality
Time Frame
1 year
Title
OS
Description
Overall survival
Time Frame
1 year
Title
QoL: quality of life: Percentage of partecipants changing their smoking habits
Description
Percentage of partecipants changing their smoking habits after trial
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: current or former smoker status; for former smokers, the maximum time since quitting smoking must be below 10 years; smoking history of at least 20 pack-years; age 45-80 years; no previous history of cancer in the 10 years before the beginning of the study; be able to stand and hold the breath for 11 seconds during image acquisition; previous participation to SOS trial. Exclusion Criteria: pregnancy
Facility Information:
Facility Name
OSCroceCarle
City
Cuneo
State/Province
CN
ZIP/Postal Code
12100
Country
Italy

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
23612466
Citation
Terzi A, Bertolaccini L, Viti A, Comello L, Ghirardo D, Priotto R, Grosso M; SOS Study Group. Lung cancer detection with digital chest tomosynthesis: baseline results from the observational study SOS. J Thorac Oncol. 2013 Jun;8(6):685-92. doi: 10.1097/JTO.0b013e318292bdef.
Results Reference
result
PubMed Identifier
25992366
Citation
Bertolaccini L, Viti A, Tavella C, Priotto R, Ghirardo D, Grosso M, Terzi A; SOS Study Group. Lung cancer detection with digital chest tomosynthesis: first round results from the SOS observational study. Ann Transl Med. 2015 Apr;3(5):67. doi: 10.3978/j.issn.2305-5839.2015.03.41.
Results Reference
result

Learn more about this trial

Lung Cancer Early Diagnosis With Digital Tomosynthesis: Re-evaluation of Lung Nodule Detection Rate at 5 Years

We'll reach out to this number within 24 hrs